Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study

Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study

Bibliographic Details
Main Author:	Hayder Al-Momen
Format:	Article
Language:	English
Published:	University of Baghdad/ Al-Kindy College of Medicine 2019-04-01
Series:	مجله كليه طب الكندي
Online Access:	https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130

Similar Items

Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of β-thalassemia and sickle cell syndromes Italian patients
by: Maria Concetta Renda, et al.
Published: (2014-09-01)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
by: Eziefula C, et al.
Published: (2022-06-01)

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
by: Murtadha Al-Khabori, et al.
Published: (2013-03-01)

Melanin nanoparticles as a potential iron chelation therapy for women with beta thalassemia during pregnancy
by: Bakhamis, N
Published: (2022)

Iron Chelation Reduces DNA Damage in Sickle Cell Anemia
by: Rawan S. Al-Khateeb, et al.
Published: (2021-10-01)

Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy
by: Kritika Goel, et al.
Published: (2022-01-01)

Assessment of iron chelation therapy adherence in patients with thalassemia major in Babylon Province
by: Mohammed Ali Al-Jabory, et al.
Published: (2023-01-01)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
by: A. Kattamis, et al.
Published: (2022-06-01)

Predictors of Non-adherence to iron chelation therapy in pediatric thalassemia patients
by: Muniba Kanwal, et al.
Published: (2022-06-01)

Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: Our experience
by: Jethani Jitendra, et al.
Published: (2010-01-01)

A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets
by: Piyush Kumar Yadav, et al.
Published: (2022-05-01)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
by: Romadhon, Pradana Zaky, et al.
Published: (2022)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
by: Romadhon PZ, et al.
Published: (2022-11-01)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011-01-01)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
by: Fortin, P, et al.
Published: (2018)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
by: Fortin, P, et al.
Published: (2016)

Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
by: Geneen, LJ, et al.
Published: (2023)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01)

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
by: Rafaa Mohamed, et al.
Published: (2022-10-01)

Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018-01-01)

Dual oral iron chelation in children with transfusion dependent beta thalassemia real world efficacy data
by: Amitoj Singh Chadha, et al.
Published: (2022-01-01)

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
by: Saliba AN, et al.
Published: (2015-06-01)

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
by: Monica Pinheiro de Almeida Verissimo, et al.
Published: (2013-01-01)

A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia
by: Paavani S. Reddy, et al.
Published: (2022-12-01)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
by: Mariane de Montalembert, et al.
Published: (2017-01-01)

Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
by: M Hashemieh
Published: (2020-08-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia
by: Habbash F, et al.
Published: (2022-12-01)

Thalassemia Intermedia: Chelator or Not?
by: Yen-Chien Lee, et al.
Published: (2022-09-01)

Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia
by: Laura Pistoia, et al.
Published: (2024-03-01)

"Evaluation Of compliance To Iron Chelation Therapy With Defe-Roxamine In Patients With Major Thalassemia In Iran In 2004 "
by: M. Izadyar, et al.
Published: (2006-06-01)

Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
by: ElMelegy Nagla T, et al.
Published: (2010-05-01)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
by: Meloni Antonella, et al.
Published: (2013-01-01)

Comparative efficacy, safety, and cost of iron chelation monotherapy vs. combination therapy in pediatric beta-thalassemia major: a single-center retrospective study
by: Dewi Sharon Simorangkir, et al.
Published: (2022-03-01)

The Non-adherence to iron chelation therapy (ICT) among transfusion-dependent thalassemia (TDT) patients in Pakistan
by: Fariha Arif, et al.
Published: (2023-08-01)

Evaluation of the Serum Level of Vascular Endothelial Growth Factor in Patients with Beta-Thalassemia Major and Sickle/Beta-Thalassemia, and its Correlation with Clinical and Laboratory Parameters
by: Sara Anmar Abdul Mohsin, et al.
Published: (2023-01-01)

Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major
by: Pradypta, Putu Gyzca, et al.

Posterior reversible encephalopathy syndrome in a known case of sickle-beta-thalassemia: a case presentation
by: Mumbaikar Kausha, et al.
Published: (2022-03-01)